Amino formulation reference

Midnight Blend

Midnight Blend is a restorative amino complex formulated to support sleep initiation , stress reduction , and neuroprotection . Designed for research into circadian rhythm modulation and neurotransmitter balance , it combines both inhibitory neurotransmitters and amino precursors associated with relaxation and sleep quality .

Source review pending1 links under reviewEducational context

Dosing literacy

Dosing & scaling, explained

No mass-based amount example with adequate calculation context is available for this compound. This is educational source context—not a protocol or recommendation.

Calculation context

No source-supported amount ladder is shown

Enter a target amount only from your own reviewed source. The calculator can convert it into concentration, volume and device markings, but it will not infer an amount from product availability or another compound.

Only mcg or mg amounts are retained. The calculator derives mL, syringe units or pen clicks from the current vial strength, water volume and device.

Schedule literacy

No independently verified schedule

Evidence context

No clinical amount or schedule is inferred from this material. Source verification is pending, and every displayed amount remains educational context rather than guidance.

Research best practices

Storage, handling and interpretation

Product identity

Verify the exact compound, formulation and amount against the product label or certificate before calculation.

Storage & handling

Follow the product label, certificate and validated laboratory SOP; no universal storage assumption is applied here.

Prepared solutions

Label concentration and preparation date, use sterile technique where applicable, and follow a validated stability protocol.

Research orientation

What researchers are exploring

These themes organize the educational information currently available. Individual claims remain under source review and are not treatment claims.

  • 01

    Melatonin

    Central regulator of circadian rhythm and sleep initiation. Molecular Formula: C 13 H 16 N 2 O 2 Molecular Weight: 232.28 g/mol

  • 02

    GABA (Gamma-Aminobutyric Acid)

    Primary inhibitory neurotransmitter in the central nervous system. Molecular Formula: C 4 H 9 NO 2 Molecular Weight: 103.12 g/mol

  • 03

    L-Taurine

    Contributes to cellular osmoregulation and muscle protection. Molecular Formula: C 2 H 7 NO 3 S / NH 2 CH 2 CH 2 SO 3 H Molecular Weight: 125.15 g/mol

  • 04

    Histidine

    Precursor to histamine, potentially balancing arousal-sleep transitions depending on context. Molecular Formula: C 6 H 9 N 3 O 2 Molecular Weight: 155.15 g/mol

  • 05

    L-Theanine

    Amino acid known for promoting calm alertness and reducing stress responses. Molecular Formula: C 7 H 14 N 2 O 3 Molecular Weight: 174.20 g/mol

  • 06

    Research

    THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. It is provided exclusively for in vitro testing and laboratory research. All product information is for educational use only, and any human or animal administration…

Evidence map

What is known—and what still needs verification

Available context is organized without assigning unsupported study models or evidence grades.

  • Source review pending

    Melatonin

    Central regulator of circadian rhythm and sleep initiation. Molecular Formula: C 13 H 16 N 2 O 2 Molecular Weight: 232.28 g/mol

  • Source review pending

    GABA (Gamma-Aminobutyric Acid)

    Primary inhibitory neurotransmitter in the central nervous system. Molecular Formula: C 4 H 9 NO 2 Molecular Weight: 103.12 g/mol

Technical reference

Identity, limitations and unknowns

Molecular profile

Molecular Formula
C 13 H 16 N 2 O 2
Molecular Weight
232.28 g/mol
PubChem CID
896
Molecular Formula
C 4 H 9 NO 2
Molecular Weight
103.12 g/mol
PubChem CID
119
Molecular Formula
C 2 H 7 NO 3 S / NH 2 CH 2 CH 2 SO 3 H
Molecular Weight
125.15 g/mol

9 additional formulation fields are omitted from this concise technical view.

Important limitations

  • Individual claims and source links have not yet completed editorial verification.
  • Evidence level, applicable study model, formulation, route and population remain unassigned.

Source review

1 links awaiting verification

  1. Source link · pmc.ncbi.nlm.nih.govVerification pending · Source review pending